DP
ELV icon

Dearborn Partners’s Elevance Health ELV Stock Holding History

Dearborn Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$467K Hold
1,208
– – 0.03% 198
2026
Q1 		$354K Sell
1,208
-73
-6% -$24K 0.02% 210
2025
Q4 		$449K Hold
1,281
– – 0.02% 192
2025
Q3 		$414K Sell
1,281
-500
-28% -$156K 0.02% 192
2025
Q2 		$693K Buy
+1,781
New +$716K 0.03% 152
2024
Q4 		– Sell
-57,547
Closed -$29.9M – 265
2024
Q3 		$29.9M Sell
57,547
-1,652
-3% -$883K 1.21% 40
2024
Q2 		$32.1M Sell
59,199
-675
-1% -$357K 1.39% 33
2024
Q1 		$31M Sell
59,874
-20,498
-26% -$10.2M 1.33% 35
2023
Q4 		$37.9M Sell
80,372
-1,359
-2% -$628K 1.38% 36
2023
Q3 		$35.6M Buy
+81,731
New +$37.1M 1.4% 36

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Dearborn Partners's ELV Position: Q2 2026 in Review

Dearborn Partners held its Elevance Health (ELV) position steady in Q2 2026 at 1,208 shares worth $467K. The position accounts for 0.03% of the portfolio, ranked #198.

Dearborn Partners first reported a position in ELV in Q3 2023 and has held it in 10 quarters since. The position peaked at $37.9M in Q4 2023. 1,606 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Dearborn Partners held 1,208 shares of Elevance Health worth $467K as of Q2 2026.
  • Dearborn Partners left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up 0.03% of Dearborn Partners's portfolio in Q2 2026, its #198 holding.
  • Dearborn Partners first reported a position in Elevance Health in Q3 2023 and has held it in 10 quarters since.
  • Dearborn Partners's Elevance Health position peaked at $37.9M in Q4 2023.
  • 1,606 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Dearborn Partners's 13F filing for Q2 2026, filed 13 Aug 2026.